Revised SPC: Bavencio (avelumab) 20 mg/mL concentrate for solution for infusion

SPC details licence extension, for use as monotherapy for first-line maintenance treatment in locally advanced or metastatic urothelial carcinoma following platinum-based chemotherapy. Also, the shelf life has now been extended to 3 years.

Source:

electronic Medicines compendium